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Abstract
Background: Process evaluations have become a valued component, alongside clinical trials, of the wider
evaluation of complex health interventions. They support understanding of implementation, and fidelity, related to
the intervention and provide valuable insights into what is effective in a practical setting by examining the context
in which interventions are implemented. The TOPSY study consists of a large multi-centre randomised controlled
trial comparing the effectiveness of pessary self-management with clinic-based care in improving women’s
condition-specific quality of life, and a nested process evaluation. The process evaluation aims to examine and
maximise recruitment to the trial, describe intervention fidelity and explore participants’ and healthcare
professionals’ experiences.
Methods: The trial will recruit 330 women from approximately 17 UK centres. The process evaluation uses a mixed-
methods approach. Semi-structured interviews will be conducted with randomised women (18 per randomised
group/n = 36), women who declined trial participation but agreed to interview (non-randomised women) (n = 20)
and healthcare professionals recruiting to the trial (n ~ 17) and delivering self-management and clinic-based care
(n ~ 17). The six internal pilot centres will be asked to record two to three recruitment discussions each (total n =
12–18). All participating centres will be asked to record one or two self-management teaching appointments (n =
30) and self-management 2-week follow-up telephone calls (n = 30). Process data (quantitative and qualitative) will
be gathered in participant completed trial questionnaires. Interviews will be analysed thematically and recordings
using an analytic grid to identify fidelity to the intervention. Quantitative analysis will be predefined within the
process evaluation analysis plan.
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Discussion: The wide variety of pessary care delivered across the UK for women with pelvic organ prolapse
presents specific localised contexts in which the TOPSY interventions will be implemented. Understanding this
contextual variance is central to understanding how and in what circumstances pessary self-management can be
implemented (should it be effective). The inclusion of non-randomised women provides an innovative way of
collecting indispensable information about eligible women who decline trial participation, allowing broader
contextualisation and considerations of generalisability of trial findings. Methodological insights from examination
of recruitment processes and mechanisms have the potential to inform recruitment mechanisms and future
recruitment strategies and study designs.
Trial registration: ISRCTN62510577. Registered on 6 October 2017.
Keywords: Process evaluation, Prolapse, Pessary, Self-management, Randomised controlled trial
Background
Contemporary trial design advocates the inclusion of a
process evaluation alongside a randomised controlled trial
(RCT) to support evaluation of complex interventions [1].
The inclusion of a process evaluation, especially in multi-
centre, pragmatic trials, has the potential to identify vari-
ation in intervention delivery across and within different
centres (fidelity), examine the mechanisms of action of the
intervention; outline the contexts in which an intervention
is implemented and aid understanding of the perspectives
of those who deliver and receive the intervention [1–6].
The TOPSY study includes a RCT (with an internal pilot),
an economic evaluation of cost-effectiveness and a nested
mixed-method process evaluation.
The trial evaluates the clinical and cost-effectiveness of
self-management of vaginal pessaries to treat pelvic
organ prolapse, compared to clinic-based care (clinic-
based follow-up) to improve women’s quality of life. Pel-
vic organ prolapse affects approximately 40% of women
over the age of 40 years [7] and is associated with a
range of distressing symptoms which negatively impact
upon a woman’s quality of life [8]. Two thirds of women
will opt to try a vaginal pessary for prolapse treatment
when it is offered [9]. Currently, the most common ser-
vice model for women treated with a vaginal pessary in
the UK is to routinely return to clinic to have their pes-
sary changed, i.e. clinic-based care [10]. No trials have
been identified that evaluate the effectiveness of self-
management in comparison to clinic-based care in im-
proving women’s quality of life when they use a pessary
for the treatment of prolapse.
The self-management intervention evaluated within
TOPSY is described in detail in the trial protocol paper
[companion paper, manuscript reference TRLS-D-19-
01151R1 [11]]. In summary, women are taught how to
manage their own pessary by a trained healthcare profes-
sional, who has experience in pessary care, in a 30-min
teaching appointment. There is one follow-up phone call
2 weeks after the teaching appointment to support self-
management and women also have a contact number to
call if they should experience difficulties at any time.
Women also receive an information leaflet about pessary
self-management. The hypothesised mechanism of ac-
tion that connects the self-management intervention and
the outcome of increased quality of life is that self-
management increases women’s self-efficacy [10].
Women in the clinic-based care group receive treatment
as usual and will be seen at regular intervals as per local
centre protocol (usually every 6 months) to have their
pessary removed and a new one inserted by a trained
healthcare professional.
The process evaluation was developed based on guid-
ance within the Medical Research Council (MRC) Frame-
work for Process Evaluation [1] and recommendations
made by the QuinteT group in relation to recruitment [6,
12–14]. The potential for the self-management interven-
tion to be more effective than clinic-based care is reliant
on successful intervention delivery, and the individual and
structural contexts that surround intervention delivery
and implementation. The process evaluation gathers data
from women in the self-management and clinic-based
care groups in order to understand how these features are
operationalised in the real world of clinical practice and
individuals’ lives. For example, understanding contextual
factors for women who are implementing self-
management at home or contextual factors that influence
the processes through which women get to clinics to re-
ceive care.
In this paper, the protocol elements relating to the
process evaluation of the TOPSY study are presented. A
companion paper describes the protocol for the trial in-
cluding the economic evaluation [manuscript reference
TRLS-D-19-01151R1 [11]].
Methods
Research question and objectives for the process
evaluation
Research question
What are the barriers and facilitators to intervention ac-
ceptability, intervention effectiveness, fidelity to delivery,
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and adherence for women treated with vaginal pessary
and the health professionals who treat them, and how
does this differ between randomised groups?
Objectives
The objectives of undertaking a nested process evalu-
ation are to:
1. Maximise recruitment (data gathered during the
internal pilot only);
2. Investigate reasons why eligible women declined
trial participation;
3. Understand women’s and healthcare professionals’
experiences of the interventions and views on
acceptability;
4. Assess adherence to allocated trial group;
5. Describe fidelity to intervention delivery; and
6. Identify contextual factors that may interact with
intervention effectiveness.
Overview of methods
The process evaluation will use mixed methods (qualita-
tive and quantitative, see Table 1), specifically:
1. Audio-recording of participant recruitment sessions
(internal pilot study only), self-management teaching ap-
pointments and self-management support phone calls;
2. Qualitative interviews with randomised women
from both trial groups, healthcare professionals
who recruit to the trial and deliver pessary self-
management and clinic-based pessary care, and
women who decline to take part in the main trial
but who are willing to be interviewed;
3. Checklist completion by health professionals on
self-management teaching sessions and 2-week
follow-up phone calls;
4. Process data (both quantitative and qualitative)
embedded within main trial data collection. For example,
an open question within the participant-completed ques-
tionnaires, and two measures of self-efficacy.
Table 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure for the study
Enrolment Allocation Follow-ups Close out On completion
of all recruitment
at a centre
Timepoint -t1 0 6months 12months 18months variable
Screening and eligibility X
Informed consent X
Interventions:
Clinic-based care
Self-management
ASSESSMENTS
Qualitative
Audio-recording of recruitment sessions X
Interviews with randomised women
(both groups)
X X
Interviews with non-randomised women
who use a pessary as treatment
X X
Interviews with health professional recruiters
and those who deliver the intervention
X
Open question with main trial questionnaires X X X X
Quantitative
General Self-Efficacy X X
Pessary Confidence Questionnaire X X X X
Quality of life X X X X
Pessary Use Questionnaire X X X X
Checklist completion about self-management
teaching appointment
X
Recording sample of self-management
teaching appointments
X
Checklist completion for 2-week follow-up
phone call
X (2 weeks after teaching)
Recording sample of 2-week follow-up calls X (2 weeks after teaching)
Bugge et al. Trials          (2020) 21:836 Page 3 of 9
Internal pilot
The objective of the internal pilot study is to ensure the
trial can recruit, randomise and retain sufficient num-
bers of participants whilst delivering the intervention as
planned. Based on work by the QuinteT group [6, 12–
16], we aim to audio-record 12–18 initial recruitment
discussions with women, as part of the internal pilot
study, to determine how the information about potential
participation in the TOPSY study is delivered and dis-
cussed (two to three women in each of the six internal
pilot centres). We expect these discussions to last be-
tween 10 and 15 min. Potential participants will receive
a one-page participant information leaflet about the
audio-recording of the initial recruitment discussion
from a delegated member of the local clinical TOPSY re-
search team. If willing to have their recruitment discus-
sion recorded, written consent will be gained prior to
the session commencing. If women do not want to take
part, the initial recruitment discussion can still take
place, but it will not be audio-recorded. If more than
one person undertakes recruitment at any of the pilot
centres, and they differ in professional background (e.g.
research nurse and consultant), recruitment recordings
will aim to reflect this diversity in professional back-
ground of recruiter. Sessions will be recorded using
small, unobtrusive digital recorders. All six pilot centres
will be asked to start recording recruitment sessions as
soon as possible after the start of recruitment at their
centre.
A subset of the interviews will be undertaken within
the internal pilot study and also analysed within the
main process evaluation data. Approximately five (of the
36 randomised interviews) and five of the interviews
with women who decline randomisation but who are
willing to be interviewed will be undertaken within the
internal pilot study. The internal pilot interview analysis
will focus on the subset of data within the interviews
where women talk about trial recruitment. A recruiter
from each of the internal pilot study centres will be
asked to take part in an interview that focusses on re-
cruitment processes. Approximately six of the self-
management teaching appointments and follow-up
phone calls will be recorded (one per pilot centre) and
analysed with a focus on fidelity to the intervention de-
livery protocol during the pilot phase.
Ongoing analysis of all the information about recruitment
and fidelity will support feedback to centres, and training of
new centres, about the optimal way to recruit women to
the study and deliver the intervention as planned.
Recruitment and consenting processes
Audio-recordings
The Participant Information Leaflet for the TOPSY trial
informs women that, if they are allocated to the self-
management group, a self-management teaching ap-
pointment or a follow-up call may be recorded with
their consent. Within the main trial consent form
women are asked to indicate ‘yes/no’ to these recording
by initialling the relevant box. Approximately 30 self-
management teaching sessions and 30 self-management
follow-up telephone calls will be recorded to achieve re-
cordings across all participating centres.
Interviews with randomised women
The main trial Patient Information Leaflet outlines that
some women will be invited for interview. The trial con-
sent form again asks women to indicate (‘yes/no’) if they
would be willing to be contacted about the interview
study.
Women who are willing to be contacted about the
interview study will be purposively sampled based on
group allocation, age, pessary user status and regional
spread. Pessary user status is differentiated between new
users, those who used a pessary for 3 months or less,
and existing users, women who have used a pessary for
more than 3 months. Pessary user status is one of the
minimisation criteria for the trial. The aim is to inter-
view 36 women in total, 18 from each trial group. It is
not possible to blind participants or the process evalu-
ation researcher to the woman’s group allocation as both
will know if the woman has received a self-management
teaching appointment. The process evaluation researcher
will post out the Interview Participant Information Leaf-
let and will call the woman a few days later to discuss
their possible participation in the interview study. An
additional consent form is signed for the interview study
prior to the first interview.
Interview study with non-randomised women
Only women who are invited to take part in the trial in
the clinic (as opposed to those who have information
posted to them), and decline in the clinic, will be asked
to take part in this component of the process evaluation.
When women decline trial participation i.e. non-
randomised women, they will be asked if they are willing
to take a recruitment pack away for an interview study
with non-randomised women. Those who indicate that
they are willing will be given a recruitment pack in
clinic. The recruitment pack will contain an introductory
letter, a Participant Information Leaflet, an expression of
interest form, a consent form and two reply-paid enve-
lopes. Participants who choose to return the expression
of interest form will be contacted by a member of the re-
search team to answer any questions, go over the con-
sent process and arrange a baseline telephone interview.
Participants are asked to sign and return the consent
form prior to the telephone interview. The aim is to
interview 20 non-randomised women.
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Healthcare professional interviews
During site initiation visits, healthcare professionals who
are identified as being part of the Local TOPSY research
team will be advised that they may be approached and
invited to take part in an interview as part of the TOPSY
study. All contact details for the Local TOPSY research
team will be collected prior to the centre being opened
to recruitment and as part of the delegation log. The
TOPSY process evaluation researcher will contact
healthcare professionals who recruit to the trial and/or
deliver the intervention (approximately n = 34; one re-
cruiter and one intervention deliverer for each trial site)
to invite them to participate in the interview by sending
them a Participant Information Leaflet. The researcher
will answer any questions they might have and provide a
consent form. Willing healthcare professionals will be
asked to return the consent form to the TOPSY Team.
Once written consent is obtained, a suitable date and
time for telephone interview will be arranged.
Data collection
The different components of the process evaluation data
collection are described below.
Audio-recording of recruitment discussions
Where potential participants consent for their recruit-
ment discussion to be recorded, the recruiter will be
asked to record the discussion. This data will be used to
highlight any barriers or facilitators to recruitment so
that recruitment can be maximised.
Audio-recording of self-management teaching
appointments and self-management support telephone
calls and checklist completion
The aim is to audio-record 30 self-management teaching
appointments and 30 2-week follow-up phone calls (at
least one self-management teaching appointment and
one phone call from each centre). Small digital recorders
will be placed, with the agreement of the woman and
healthcare professional, in the consulting room or at-
tached to the phone to record all instruction and sup-
port given. Consent for these recordings is included
within the main trial consent form and will be checked
verbally before each recording. Variance across the sam-
ple will be aimed for in treating healthcare professional
(nurse/physiotherapist/doctor) and women’s age. Check-
lists, that aim to assess fidelity, will be completed by the
health care professional involved in the session/call for
all self-management teaching appointments and all 2-
week follow-up calls. The recordings and checklists will
provide information about fidelity of intervention
delivery.
Interviews with randomised women
Thirty-six women will be recruited (18 in the self-
management group and 18 in the clinic-based care
group). Purposive sampling will aim for variance in age,
treating healthcare professional (nurse/physiotherapist/
doctor), and centre type (outpatient/community/primary
care). Interviews will be semi-structured and face-to-face
and occur at randomisation and 18months post-
randomisation (where the primary outcome is mea-
sured). The interviews will explore perspectives on re-
cruitment (baseline), symptoms and quality of life
(baseline)/ change in symptoms and quality of life (18
months), experience and acceptability of self-
management or clinic-based care (18 months), adherence
to the allocated trial group (18 months), and contextual
factors that are perceived to interact with the effective-
ness of the intervention (18 months). Where participants
have crossed over to receive treatment offered in the
group to which she was not randomised, reasons for
doing so will be explored during the 18-month follow-
up interview.
All interview schedules will be developed with our Pa-
tients and Public Involvement (PPI) co-applicant and
other PPI representatives. All interviews will be digitally
recorded.
Interviews with women who decline randomisation
Twenty women who are potential participants for the
trial and do not consent to randomisation, but who do
consent to taking part in an interview, will be inter-
viewed at baseline by telephone using a semi-structured
interview schedule. If women consent to future partici-
pation in the interview study they will also be inter-
viewed by phone at 18 months. Interviews will focus on
reasons for declining trial participation (baseline); symp-
toms and quality of life (baseline)/ change in symptoms
and quality of life (18 months); treatment received for
prolapse (18 months); and contextual factors that may
interact with future service implementation (baseline
and 18months).
Interviews with healthcare professionals who recruit to the
trial and deliver the interventions
At least one healthcare professional who has delivered
the self-management and/or clinic-based care interven-
tion at each centre and a recruiter to the TOPSY trial
will be given an information leaflet and invited to take
part in a telephone interview study. Sampling will aim
for diversity of professional group both for recruitment
and for delivery. Recruiters and those who deliver inter-
ventions from the pilot centres will be interviewed at the
end of the pilot phase. All other interviews will take
place after trial recruitment is complete. Interviews will
be semi-structured, last approximately 30 min and be
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undertaken by telephone. For recruiters, interviews will
focus on factors that influence the identification of po-
tential participants and recruitment, including service
structures, contributing to maximising recruitment For
those who have been involved in delivering clinic-based
pessary care and/or self-management, interviews will
focus on experiences of delivering self-management/
clinic-based care, including variance in delivery and rea-
sons for the variance, and contextual factors that were
perceived to impact upon delivery. The objective here is
to understand fidelity and contextual factors.
Process data embedded within main trial data collection
Within the main trial participant completed question-
naire there is a Pessary Use questionnaire within which
there an open question that assesses women’s experience
of their trial group (self-management or clinic-based
care). Analysis of the responses to this question will sup-
port understanding of women’s experience of, and ad-
herence to, their trial group.
The main trial questionnaire also contains the General
Self-efficacy Questionnaire [17] and a pessary confidence
questionnaire, developed specifically for the TOPSY
study (described in detail in the trial protocol). These
quantitative data will be analysed as part of the process
evaluation analysis to explore the mediating influence of
self-efficacy on quality of life.
Data analysis
All analyses will be conducted according to a process
evaluation analysis plan. The analysis plan will be ap-
proved by the Trial Steering Committee.
Qualitative data analysis
Initially, each individual data source will be analysed
separately, and subsequently, findings will be synthesised
across data sources. Qualitative data sources will be
transcribed verbatim and entered into NVivo 12 (QSR
International Pty Ltd., 2018. NVivo qualitative data ana-
lysis Software) for data management. Ten percent of
transcripts within each data source will be coded inde-
pendently by two analysts to assess for consistency in
coding. All of the analysis described below will be under-
taken by the process evaluation subgroup of grant-
holders. Analysis will not be shared with the wider
grant-holding group until the main trial findings are re-
vealed. The process evaluation researcher will be blinded
to the result of the clinical effectiveness findings during
all stages of the analysis process described here.
The following qualitative data will be analysed using
the Framework Approach to analysis [18]: audio-
recordings of recruitment sessions; interviews with ran-
domised women, women who declined randomisation
and healthcare professionals; and the open question
within the questionnaire.
Framework Analysis will move through stages of data
management, descriptive analysis and finally onto inter-
pretive and explanatory analysis.
For each individual dataset, the recommended Frame-
work stages will be followed:
1. Data management
Familiarisation of the researcher with the data is the
first step towards analysis. In keeping with Framework
Analysis methods [18], the initial thematic framework
for each dataset will be developed from the research
questions, the data collection tools (e.g. interview sched-
ules), themes that have arisen iteratively from the famil-
iarisation process; discussion with co-applicants, and PPI
consultation. In this way, the initial thematic framework
contains both deductive and inductive elements. The
thematic framework will then be inductively developed
with the women’s voices shaping the analysis. Involving
PPI representatives and the qualitative analysis team
throughout will ensure that the thematic framework will
be reviewed routinely and alternative ways of analysing
the data considered.
2. Abstraction and interpretation
Abstraction and interpretation will occur first for
each individual dataset and then the datasets will be
combined. During this stage, categories and linkages
within each dataset will be developed through com-
parison of tables and analytic memos. This process
will be repeated for each of the purposes of the
process evaluation to develop one overarching matrix
for each purpose [19], e.g. bringing the tables to-
gether that focus on maximising recruitment into one
matrix. Explanation will aim to bring the data to-
gether to interpret why the data have come together
in the specific way that is presented.
Audio-recordings of the self-management teaching
appointments and the self-management follow-up
phone calls will be analysed by developing a struc-
tured analytic grid using the intervention protocols
and the theory underlying the protocols. The grid
will assess for key features within the teaching ap-
pointments and phone calls, for example, whether
the healthcare professional teaching self-management
offer the woman an opportunity to practice taking
the pessary out and replacing it. The grid will con-
tain explicit guidance as to what codes have to be
applied in what circumstances. Coded data will then
be subject to quantitative descriptive and interpretive
analysis.
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Quantitative data analysis for the process evaluation
Data collected from the pessary use questionnaire,
general self-efficacy scale and the pessary confidence
questionnaire will be analysed using quantitative
methods. Data from the self-management appoint-
ments and 2-week follow-up calls (checklists and re-
cordings) will also be analysed quantitatively with a
particular focus on fidelity, such as the percentage of
women who have been able to (1) remove and (2) re-
place their pessary themselves.
All process evaluation quantitative analyses will be
conducted according to the pre-specified quantitative el-
ements of the process evaluation analysis plan where
possible using Stata version 15. All quantitative data will
be described with the appropriate descriptive statistics:
mean and standard deviation (SD) for continuous out-
comes (or medians and interquartile range for skewed
data), and counts and percentages for dichotomous and
categorical outcomes.
We will undertake a statistical mediation analysis to
investigate the extent to which any observed effect of
self-management on women’s quality of life (measured
using PFIQ-7 [20] at 18 months) is mediated by self-
efficacy. Single-mediator models will individually as-
sess the General Self-Efficacy scale and items from
pessary confidence questionnaire as potential mediat-
ing factors.
Triangulation of process evaluation analysis
The quantitative and qualitative process evaluation ana-
lysis will be brought together using triangulation [19]. A
matrix will be developed for each process evaluation
concept (e.g. a matrix will focus on fidelity to the self-
management intervention). The matrix will bring to-
gether the data sources and the relevant concept. The
agreement/disagreement across sources will be
documented.
A process evaluation management group oversees all
aspects of the process evaluation, including the analysis.
The group consists of the Process Evaluation Researcher,
the Process Evaluation Lead, a clinical co-applicant and
a PPI representative. The PPI representative will be in-
volved in the analysis and interpretation of the data.
Discussion
The TOPSY study will provide a novel comparison, from
multiple methods, between self-management and clinic-
based pessary care in the UK for women with pelvic
organ prolapse using a vaginal pessary. Those perspec-
tives will support an understanding of pessary self-
management from an effectiveness, patient, healthcare
professional and economic viewpoint. The process evalu-
ation specifically will support new understanding of the
contextual features that may influence intervention
delivery and implementation in clinical practice and
within women’s lives, as well as support and deepen our
understanding about trial recruitment.
In this process evaluation, we have aimed to build
on reports of contemporary process evaluation design
[1] and good practice in trial recruitment [6, 12–16].
We plan to examine recruitment processes from mul-
tiple perspectives to better understand local structural
elements of this multi-centre RCT with a view to
maximising overall trial recruitment. It will be inter-
esting to explore whether, or not, this embedded re-
cruitment work enhances trial recruitment. The
inclusion of eligible women who have declined trial
participation is another distinctive part of this process
evaluation. This inclusion is anticipated to strengthen
our understanding of how women feel about partici-
pating in an RCT regarding vaginal pessary manage-
ment and the acceptability of recruitment processes
and materials. It further offers the opportunity for a
qualitative comparison of participant characteristics of
randomised trial participants and women declining
participation.
Having built the process evaluation into the study de-
sign from the outset will strengthen the overall out-
comes. In its comprehensiveness, the process evaluation
looks at what works for whom and how by including pa-
tient and healthcare perspectives. Local structural differ-
ences are recorded in various ways providing valuable
contextual information which allows a deeper analysis of
the mechanisms of the implementation. Some re-
searchers have questioned the suitability of process eval-
uations as part of an RCT as they see them as two
ontologically opposing elements [21, 22]. Whilst it is
challenging to separate specific mechanisms from each
other to determine exactly which ones have an impact
on intervention outcomes, not acknowledging the im-
portance of contextual factors on the potential success
of an intervention, dismisses the opportunity to find po-
tential solutions and avenues for adjustments to poten-
tial obstacles to successfully implement a healthcare
intervention.
Current status of process evaluation
Recruitment and data collection are ongoing across all
centres across the UK. Recruitment started (to the trial
and process evaluation) in May 2018 and is expected to
continue until January 2020. Data collection and recruit-
ment for the recruitment discussion recordings, which
was limited to internal pilot centres, is complete. The
pilot study was completed on 16th November 2018. It is
anticipated that data collection for the process evalu-
ation will be complete by July 2021, 18 months after the
last randomisation.
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Trial status
The first participant to the trial was randomised on the
16th May 2018. The first participant for the randomised
interview study was consented on 14 June 2018. The
first participant for the non-randomised interview study
was consented on 29 August 2018. Recruitment and
consenting for audio-recordings of the self-management
teaching appointments and follow-up calls is ongoing
and is anticipated to be completed February 2020. Re-
cruitment and consenting for interviews with healthcare
professionals recruiting to TOPSY and delivering the
TOPSY intervention is ongoing and anticipated to be
completed in April 2020. Recruitment to the trial will
continue until January 2020. Data collection for the trial
will continue until 2021.The protocol version 5 pre-
sented here received ethical approval on 25th July 2019.
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